64 related articles for article (PubMed ID: 36290816)
1. A Prognostic Nomogram Based on Log Odds of Positive Lymph Nodes to Predict Overall Survival for Non-Metastatic Bladder Cancer Patients after Radical Cystectomy.
Yang J; Huang H; Li W; Ran S; Hu J; Zhang Y; Li W; Chen C; He W
Curr Oncol; 2022 Sep; 29(10):6834-6846. PubMed ID: 36290816
[TBL] [Abstract][Full Text] [Related]
2. A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data.
He C; Ni M; Liu J; Teng X; Ke L; Matsuura Y; Okuda K; Sakairi Y; Cheng J; Yu L; Lv W; Hu J
Transl Lung Cancer Res; 2024 Mar; 13(3):573-586. PubMed ID: 38601448
[TBL] [Abstract][Full Text] [Related]
3. A novel nomogram based on body composition and nutritional indicators to predict the prognosis of patients with muscle-invasive bladder cancer undergoing radical cystectomy.
Zhong X; Pan Y; Wu K; Wang L; Dou P; Tan P; Zhang P; Li X
Cancer Med; 2023 Dec; 12(24):21627-21638. PubMed ID: 37975152
[TBL] [Abstract][Full Text] [Related]
4. A novel log odds of positive lymph nodes-based nomogram for predicting overall survival in patients with colorectal signet ring cell carcinoma: a SEER population-based study.
Yu W; Xu B; Li P
Int J Colorectal Dis; 2024 Apr; 39(1):44. PubMed ID: 38558258
[TBL] [Abstract][Full Text] [Related]
5. A Prognostic Model Based on the Log Odds Ratio of Positive Lymph Nodes Predicts Prognosis of Patients with Rectal Cancer.
Li J; Yang YZ; Xu P; Zhang C
J Gastrointest Cancer; 2024 May; ():. PubMed ID: 38700666
[TBL] [Abstract][Full Text] [Related]
6. A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection.
Xie X; Kang M; Qu Z; Gu K
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17241-17251. PubMed ID: 37804427
[TBL] [Abstract][Full Text] [Related]
7. Log odds of positive lymph nodes (LODDS)-based novel nomogram for survival estimation in patients with invasive micropapillary carcinoma of the breast.
Meng X; Hao F; Wang N; Qin P; Ju Z; Sun D
BMC Med Res Methodol; 2024 Apr; 24(1):90. PubMed ID: 38637725
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of log odds of positive lymph nodes (LODDS)-based nomograms for predicting overall survival and cancer-specific survival in ovarian clear cell carcinoma patients.
Liu Z; Jing C; Hooblal YM; Yang H; Chen Z; Kong F
Front Oncol; 2024; 14():1370272. PubMed ID: 38577328
[TBL] [Abstract][Full Text] [Related]
9. A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database.
Teng L; Du J; Yan S; Xu P; Liu J; Zhao X; Tao W
Breast Cancer; 2024 May; ():. PubMed ID: 38802681
[TBL] [Abstract][Full Text] [Related]
10. Different lymph node staging systems for predicting the prognosis of colorectal neuroendocrine neoplasms.
Zhang YY; Cai YW; Zhang X
World J Gastrointest Oncol; 2024 May; 16(5):1745-1755. PubMed ID: 38764820
[TBL] [Abstract][Full Text] [Related]
11. Nomogram for predicting postoperative ileus after radical cystectomy and urinary diversion: a retrospective single-center study.
Sun X; Liu C; Zhang C; Zhang Z
Ann Med; 2024 Dec; 56(1):2329125. PubMed ID: 38498939
[TBL] [Abstract][Full Text] [Related]
12. A predictive nomogram developed and validated for gastric cancer patients with triple-negative tumor markers.
Xu Y; Zhang P; Luo Z; Cen G; Zhang S; Zhang Y; Huang C
Future Oncol; 2024 May; 20(14):919-934. PubMed ID: 37920954
[No Abstract] [Full Text] [Related]
13. Identifying Optimal Candidates for Trimodality Therapy among Nonmetastatic Muscle-Invasive Bladder Cancer Patients.
Ran S; Yang J; Hu J; Fang L; He W
Curr Oncol; 2023 Nov; 30(12):10166-10178. PubMed ID: 38132374
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a nomogram to predict lymph node metastasis in patients with progressive muscle-invasive bladder cancer.
Qiao Y; Jia Y; Luo L; Li B; Xie F; Wang H; Li S
Front Oncol; 2024; 14():1342244. PubMed ID: 38817904
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for customized recurrence prediction in primary non-muscle-invasive bladder cancer based on routine blood and urine parameters.
He Y; Pan C; Zhang Y; Lv M; Yang B
BMC Urol; 2024 Mar; 24(1):67. PubMed ID: 38528549
[TBL] [Abstract][Full Text] [Related]
16. Application and subgroup analysis of competing risks model based on different lymph node staging systems in differentiated thyroid cancer.
Cao ZX; Huang JS; Wang MM
Updates Surg; 2024 May; ():. PubMed ID: 38691331
[TBL] [Abstract][Full Text] [Related]
17. A Novel Decision Tree Model for Predicting the Cancer-Specific Survival of Patients with Bladder Cancer Treated with Radical Cystectomy.
Sarrio-Sanz P; Martinez-Cayuelas L; Beltran-Perez A; Muñoz-Montoya M; Segura-Heras JV; Gil-Guillen VF; Gomez-Perez L
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673449
[No Abstract] [Full Text] [Related]
18. Comparisons of different lymph node staging systems for predicting overall survival of node-positive patients with renal cell carcinoma: a retrospective cohort study using the Surveillance, Epidemiology and End Results database.
Zheng W; Jiang W; Wu Q; Chen J; Zhang Z; Yu S; Guo C
BMJ Open; 2023 Apr; 13(4):e068044. PubMed ID: 37185648
[TBL] [Abstract][Full Text] [Related]
19. Prognostic nomogram based on the lymph node metastasis indicators for patients with bladder cancer: A SEER population-based study and external validation.
Li S; Wang Y; Hu X
Cancer Med; 2023 Mar; 12(6):6853-6866. PubMed ID: 36479835
[TBL] [Abstract][Full Text] [Related]
20. Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.
Li Y; Xiu L; Ma M; Seery S; Lou X; Li K; Wu Y; Liang S; Wu Y; Cui W
Front Oncol; 2022; 12():940601. PubMed ID: 36439411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
